Skip to main content
NCBI home page
Alzheimer's Research & Therapy logoLink to Alzheimer's Research & Therapy
. 2024 Jul 27;16:168. doi: 10.1186/s13195-024-01538-0

Correction: Diagnostic performance of plasma pTau217, pTau181, Aβ1‑42 and Aβ1‑40 in the LUMIPULSE automated platform for the detection of Alzheimer disease

Javier Arranz 1,2,3, Nuole Zhu 1,3,4, Sara Rubio-Guerra 1,3, Íñigo Rodríguez-Baz 1,2, Rosa Ferrer 5, María Carmona-Iragui 1,2,4, Isabel Barroeta 1,2,4, Ignacio Illán-Gala 1,4, Miguel Santos-Santos 1,4, Juan Fortea 1,2,4, Alberto Lleó 1,4, Mireia Tondo 5,6,✉, Daniel Alcolea 1,4,✉
PMCID: PMC11282706  PMID: 39068457

Correction: Alz Res Therapy 16, 139 (2024)

10.1186/s13195-024-01513-9.

Following publication of the original article [1], the authors corrected the Funding section to mention “project PI22/00611”.

The original article [1] has been corrected.

Footnotes

The online version of the original article can be found at 10.1186/s13195-024-01513-9.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Contributor Information

Mireia Tondo, Email: mtondo@santpau.cat.

Daniel Alcolea, Email: dalcolea@santpau.cat.

References

  • 1.Arranz J, Zhu N, Rubio-Guerra S, et al. Diagnostic performance of plasma pTau217, pTau181, Aβ1-42 and Aβ1-40 in the LUMIPULSE automated platform for the detection of Alzheimer disease. Alz Res Therapy. 2024;16:139. 10.1186/s13195-024-01513-9. 10.1186/s13195-024-01513-9 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Alzheimer's Research & Therapy are provided here courtesy of BMC

RESOURCES